NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SILK stock has increased by 5.3% and is now trading at $39.09. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical.

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Silk Road Medical.

Silk Road Medical Inc (NASDAQ:SILK) issued its quarterly earnings data on Thursday, April, 30th. The company reported ($0.32) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.31) by $0.01. The business had revenue of $18.93 million for the quarter, compared to analysts' expectations of $19.79 million. Silk Road Medical had a negative return on equity of 44.17% and a negative net margin of 54.94%. The business's revenue for the quarter was up 48.3% compared to the same quarter last year. During the same period in the prior year, the business posted ($20.12) earnings per share. View Silk Road Medical's earnings history.

Silk Road Medical updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $92-95 million, compared to the consensus revenue estimate of $94.02 million.

2 analysts have issued twelve-month target prices for Silk Road Medical's shares. Their forecasts range from $47.00 to $52.00. On average, they anticipate Silk Road Medical's stock price to reach $49.50 in the next year. This suggests a possible upside of 26.6% from the stock's current price. View analysts' price targets for Silk Road Medical.

Media headlines about SILK stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Silk Road Medical earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutSilk Road Medical.

Silk Road Medical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,270,000 shares, an increase of 5.6% from the April 15th total of 2,150,000 shares. Based on an average trading volume of 323,700 shares, the days-to-cover ratio is currently 7.0 days. Currently, 9.8% of the company's stock are short sold. View Silk Road Medical's Current Options Chain.

Some companies that are related to Silk Road Medical include Nevro (NVRO), Integra Lifesciences (IART), ICU Medical (ICUI), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Inovio Pharmaceuticals (INO), AtriCure (ATRC), Glaukos (GKOS), Cantel Medical (CMD), Luminex (LMNX), Shockwave Medical (SWAV), Axonics Modulation Technologies (AXNX) and Cardiovascular Systems (CSII). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Honeywell International (HON), Splunk (SPLK), Thermo Fisher Scientific (TMO), CVS Health (CVS), DexCom (DXCM), Raytheon Technologies (RTX) and Veeva Systems (VEEV).

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Silk Road Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Capital World Investors (5.64%), BlackRock Inc. (5.29%), Janus Henderson Group PLC (5.22%), Alliancebernstein L.P. (4.63%), Wasatch Advisors Inc. (4.60%) and Jennison Associates LLC (4.26%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View institutional ownership trends for Silk Road Medical.

SILK stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Janus Henderson Group PLC, Alyeska Investment Group L.P., Atom Investors LP, TimesSquare Capital Management LLC, Cannell Peter B & Co. Inc., Rhenman & Partners Asset Management AB, and Nuveen Asset Management LLC. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, and Richard Ruedy. View insider buying and selling activity for Silk Road Medical.

SILK stock was purchased by a variety of institutional investors in the last quarter, including Capital World Investors, Wasatch Advisors Inc., Invesco Ltd., Capital International Investors, Frontier Capital Management Co. LLC, Clearbridge Investments LLC, BlackRock Inc., and Thrivent Financial for Lutherans. View insider buying and selling activity for Silk Road Medical.

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SILK stock can currently be purchased for approximately $39.09.

Silk Road Medical has a market capitalization of $1.23 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe.

The official website for Silk Road Medical is www.silkroadmed.com.

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]